Tilray stock jumped today after the Washington Post reported that Trump plans to reclassify marijuana as a Schedule III drug. The report says an executive order could come as early as January. This would help cannabis companies with banking access and tax burdens, but it isn't full legalization. Just be aware that Tilray hasn't turned a profit since 2018, even with full legalization in its home market of Canada.